ALB and Cirrhosis: The decision-tree methodology allowed for the synthesis of evidence from multiple clinical trials conducted in Europe with albumin and multiple comparators to evaluate the cost-effectiveness of albumin in the treatment of decompensated cirrhosis requiring LVP with SBP or with HRS.